Kythera deal

[HairlossAt15]

I'm not hopelessly optimistic, because I've been losing my hair for long enough (3 years). But, I gotta say, it really looks like things are falling into place.

Can I have a new of the bill or a link to an article about it. Just curious

[It's2014ComeOnAlready]

Can I have a new of the bill or a link to an article about it. Just curious

http://energycommerce.house.gov/sites/republicans.energycommerce.house.gov/files/114/Cures2015FACTSHEET.pdf

[It's2014ComeOnAlready]

Many of us, no wait.... damn near all of us don't or won't give a rats ass about accelerating setipirant as a hair loss treatment. Just release it already. The same goes for Follica and anything to do with stem cells.

I'd agree with you, but unfortunately it doesn't work that way. I'm trying to give relevant information. Yes, people will care if Setipiprant is accelerated, because the alternative is waiting longer.

You know, for a guy who does a lot of bitching and moaning about the speed of FDA trials, I'm surprised you're not interested when finding out there's a strong likelihood they'll be sped up.

[Sogeking]

http://energycommerce.house.gov/site...5FACTSHEET.pdf

When is that supposed to come in front of congress?
Is the exact date known?

[It's2014ComeOnAlready]

When is that supposed to come in front of congress?
Is the exact date known?

In a couple weeks according to everything I've read

[dus]

You know, for a guy who does a lot of bitching and moaning about the speed of FDA trials, I'm surprised you're not interested when finding out there's a strong likelihood they'll be sped up.

Quite funny really.

[Hankylord]

Could this be a way for Allergan to overcome the issue with other companies legally being able to produce bimatoprost? They could market seti/bim together (akin to something like the Proactiv set of products), creating an uphill battle in terms of brand loyalty/market recognition for any other bimatoprost supplier.

This would mean that it may be in Allergan's interests to delay the production of bimatoprost until they can go ahead with a dual release after seti's trials have finished.

[schtif]

Could this be a way for Allergan to overcome the issue with other companies legally being able to produce bimatoprost? They could market seti/bim together (akin to something like the Proactiv set of products), creating an uphill battle in terms of brand loyalty/market recognition for any other bimatoprost supplier.

This would mean that it may be in Allergan's interests to delay the production of bimatoprost until they can go ahead with a dual release after seti's trials have finished.

I hope that is not the case, since they are only about to file an Investigational New Drug (IND) application for seti. That would (being optimistic and assuming bim is working) delay the whole process for quite a while...